Clinical Trial Update: Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating brostallicin in patients with locally advanced or metastatic soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Soft Tissue Sarcoma

Drugs mentioned

• Brostallicin (brostallicin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Gastrointestinal Stromal Tumor, Sarcoma | Phase 2 | Status: COMPLETED